黄连素对肝癌Hep-G2细胞株的作用研究
Effect and Mechanism of Berberine on Human Hepatocellular Carcinoma Cell Line Hep-G2
DOI: 10.12677/TCM.2018.72026, PDF,  被引量    国家自然科学基金支持
作者: 王敏:湖北中医药大学2015级研究生班,湖北 武汉;张志敏, 章必成, 杨 波, 刘 兰, 付红星, 饶智国:解放军武汉总医院肿瘤科,湖北 武汉
关键词: 黄连素肝癌细胞增殖细胞凋亡BTG2细胞周期蛋白B1细胞周期蛋白D1Berberine Hepatocellular Carcinoma Cell Proliferation Cell Apoptosis BTG2 CyclinB1 Cyclin D1
摘要: 目的:探讨黄连素(berberine, BBR)作用于肝癌Hep-G2细胞增殖和凋亡的机制。方法:CCK-8法检测BBR对Hep-G2细胞增殖的抑制作用;流式细胞术检测BBR对细胞凋亡的影响;蛋白印迹法(Western blotting)及实时荧光定量PCR (RT-PCR)检测抗增殖基因BTG2及细胞周期蛋白CyclinB1、CyclinD1的蛋白及mRNA表达的情况。结果:与对照组相比,BBR可以抑制肝癌Hep-G2细胞的增殖,且抑制率与BBR浓度成正比,差异具有统计学意义(p < 0.01);与对照组相比,BBR可诱导细胞凋亡(p < 0.01),且凋亡率随着黄连素的作用时间的延长而增加(p < 0.01);BTG2 mRNA的表达随着BBR作用时间的延长逐渐增强(p < 0.01),且与对照组相比,差异具有显著性(p < 0.01),而CyclinB1、CyclinD1mRNA的表达则随着BBR作用时间的延长逐渐减弱(p < 0.01或p < 0.05),与对照组相比,差异具有显著性(P < 0.01);与对照组相比,BTG2和CyclinB1、CyclinD1蛋白表达的差异具有显著性(p < 0.05)。结论:BBR可抑制肝癌细胞Hep-G2的增殖,诱导细胞凋亡,其机制可能与其上调抗增殖基因BTG2和下调细胞周期蛋白CyclinB1、CyclinD1的表达有关。
Abstract: Objective: To investigate the effect and mechanism of Berberine on inhibiting cell proliferation and inducing apoptosis in Hepatocellular carcinoma Hep-G2 cell line. Methods: The inhibitory ef-fect of Berberine on the proliferation of Hep-G2 cells was detected by CCK-8 method; effect of Berberine on cell apoptosis by flow cytometry (FCM); western blotting and real time fluorescent quantitative PCR (RT-PCR) analysis were used to detect the mRNA and protein expression of anti proliferation gene BTG2 and CyclinB1, cyclin D1. Results: The proliferation of Hep-G2 cell lines was inhibited by Berberine in a dose and time dependent manner, and compared with the control group, the difference was statistically significant (p < 0.01). Berberine promotes cell apoptosis, and the rate of apoptosis is proportional to the effect time of Berberine (P < 0.01). The expression of BTG2 mRNA increased with the time of Berberine treatment (p < 0.01), and compared with the control group, there’s significant difference (p < 0.01); while the expression of CyclinB1, CyclinD1 mRNA was gradually decreased with the time of Berberine intervention (p < 0.01 or p < 0.05), and the difference was significantly compared with the control group (p < 0.01). Compared with the control group, the differential expression of BTG2 and CyclinB1, CyclinD1 protein was significant (p < 0.05). Conclusions: Berberine can inhibit the proliferation of Hep-G2 cells and induce cells apoptosis, which mechanism may be related to the up-regulation of BTG2 and down-regulation of CyclinB1, Cyclin D1 by berberine.
文章引用:王敏, 张志敏, 章必成, 杨波, 刘兰, 付红星, 饶智国. 黄连素对肝癌Hep-G2细胞株的作用研究[J]. 中医学, 2018, 7(2): 158-166. https://doi.org/10.12677/TCM.2018.72026

参考文献

[1] Torre, L.A., Bray, F., Siegel, R.L., et al. (2015) Global Cancer Statistics, 2012. Ca A Cancer Journal for Clinicians, 65, 87-108. [Google Scholar] [CrossRef] [PubMed]
[2] Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. Ca A Cancer Journal for Clinicians, 66, 115. [Google Scholar] [CrossRef] [PubMed]
[3] Gong, X.L. and Qin, S.K. (2016) Review and Present Status of Systematic Treatment of Advanced Hepatocellular Carcinomain in 30 Years. Practical Journal of Oncology, 31, 357-397.
[4] Hano, K. (1959) The Carcinostatic Effects of Some Plant Components and Their Related Compounds. Acta-Unio Internationalis Contra Cancrum, 15, 122.
[5] Liu, B., Wang, G., Yang, J., et al. (2011) Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes. PLoS ONE, 6, e21416. [Google Scholar] [CrossRef] [PubMed]
[6] Ren, K., Zhang, W., Wu, G., et al. (2016) Synergistic Anti-Cancer Effects of Galangin and Berberine through Apoptosis Induction and Proliferation Inhibition in Oesophageal Carcinoma Cells. Biomedicine & Pharmacotherapy, 84, 1748-1759. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, Q., Wang, J.F. and Ma, J.X. (2013) Radiosensitizing Effect of Berberine on Nude Mice Transplanted with LNCaP Cells of Prostate Cancer. Chinese Journal of Clinicians, 7, 11549-11552.
[8] Eo, S.H., Kim, J.H. and Kim, S.J. (2015) Induction of G2/M Arrest by Berberine via Activation of PI3K/Akt and p38 in Human Chondrosarcoma Cell Line. Oncology Research, 22, 147-157. [Google Scholar] [CrossRef
[9] Seo, Y.S., Yim, M.J., Kim, B.H., et al. (2015) Berberine-Induced Anticancer Activities in FaDu Head and Neck Squamous Cell Carcinoma Cells. Oncology Reports, 34, 3025-3034. [Google Scholar] [CrossRef] [PubMed]
[10] Lei, B.T. and Ma, C.Y. (2014) Research Progress on Anti-Hepatocarcinoma of Berberine. Chinese Archives of Traditional Chinese Medicine, 32, 254-256.
[11] La, X., Zhang, L., Li, Z., et al. (2017) Berberine-Induced Autophagic Cell Death by Elevating GRP78 Levels in Cancer Cells. Oncotarget, 8, 20909-20924. [Google Scholar] [CrossRef] [PubMed]
[12] Mao, B., Zhang, Z. and Wang, G. (2015) BTG2: A Rising Star of Tumor Suppressors (Review). International Journal of Oncology, 46, 459-464. [Google Scholar] [CrossRef] [PubMed]
[13] Gao, S.S., Yang, X.H. and Wang, M. (2016) Inhibitory Effects of B-Cell Translocation Gene 2 on Skin Cancer Cells via the Wnt/β-Catenin Signaling Pathway. Molecular Medicine Reports, 14, 3464-3468. [Google Scholar] [CrossRef] [PubMed]
[14] Rouault, J.P., Falette, N., Guéhenneux, F., et al. (1996) Identification of BTG2, an Antiproliferative p53-Dependent Component of the DNA Damage Cellular Response Pathway. Nature Genetics, 14, 482-486. [Google Scholar] [CrossRef] [PubMed]
[15] Lee, J.C., Chung, L.C., Chen, Y.J., et al. (2015)Upregulation of B-Cell Translocation Gene 2 by Epigallocatechin-3-Gallate via p38 and ERK Signaling Blocks Cell Proliferation in Human Oral Sduamous Cell Carcinoma Cells. Cancer Letter, 360, 310-318. [Google Scholar] [CrossRef] [PubMed]
[16] Micheli, L., Ceccarelli, M., Fariolivecchioli, S., et al. (2015) Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 Genes. Journal of Cellular Physiology, 230, 2881-2890. [Google Scholar] [CrossRef] [PubMed]
[17] Takahashi, F., Chiba, N., Tajima, K., et al. (2011) Breast Tumor Progression Induced by Loss of BTG2 Expression Is Inhibited by Targeted Therapy with the RrbB/HER Inhibitor Lapatinib. Oncogene, 30, 3084-3095. [Google Scholar] [CrossRef] [PubMed]
[18] Karve, T.M. and Rosen, E.M. (2012) B-Cell Translocation Gene 2 (BTG2) Stimulates Cellular Antioxidant Defenses through the Antioxidant Transcription Factor NFE2L2 in Human Mammary Epithelial Cells. The Journal of Biological Chemistry, 287, 31503-31514. [Google Scholar] [CrossRef
[19] Takahashi, M., Hayashida, T., Okazak, H., et al. (2014) Loss of B-Cell Translocation Gene 2 Expression in Estrogen Receptor-Positive Breast Cancer Predicts Tamoxifen Resistance. Cancer Science, 105, 675-682. [Google Scholar] [CrossRef] [PubMed]
[20] Tsui, K.H., Chung, L.C., Feng, T.H., et al. (2012) Up-Regulation of Prostate-Derived Ets Factor by Luteolin Causes Inhibition of Cell Proliferation and Cell Invasion in Prostate Carcinoma Cells. International Journal of Cancer, 130, 2812-2823. [Google Scholar] [CrossRef] [PubMed]
[21] Li, W.Q., Yu, H.Y. and Zhong, N.Z. (2015) miR-27a Suppresses the Clonogenic Growth and Migration of Human Glioblastoma Multiforme Cells by Targeting BTG2. International Journal of Oncology, 46, 1601-1608. [Google Scholar] [CrossRef] [PubMed]
[22] Ye, Y., Xiao, H., Luo, J., et al. (2017) Expression and Clinical Significance of B Cell Translocation Gene 2 in Primary Hepatocellular Carcinoma. Journal of Third Military Medical University, 39, 685-690.
[23] Han, P., Wang, Q.L. and Zhang, X. (2016) Expression of TRAP1 in Gastric Cancer Tissue and Its Correlation with Malignant Biology. Asian Pacific Journal of Tropical Medicine, 9, 64-68. [Google Scholar] [CrossRef] [PubMed]
[24] Xia, H., Xiang, S.L., Zeng, Y., et al. (2016) Overexpression of Chk 1/2 Gene G2/M Arrest in MGC803 Cells Induced by Affects Diallyl Disulfide. Chinese Pharmacological Bulletin, No. 2, 199-204.
[25] Li, Q.Y., Hao, Y.R., Qin, J., et al. (2016) Effect of BIX-01294 on Cell Proliferation of Liver Cancer. Chinese Journal of Cancer Prevention and Treatment, 23, 487-492.
[26] Xu, T., Zhong, L., Gan, L.-G., et al. (2016) Effects of LG268 on Cell Proliferation and Apoptosis of NB4 Cells. International Journal of Medical Sciences, 13, 517-523. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, T., Li, W.-M., Wang, W.-P., et al. (2016) Inhibiting CREPT Reduces the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Down-Regulating Cell Cycle Related Protein. American Journal of Translational Research, 8, 2097-2113.
[28] Zhou, J., Li, L.U., Fang, L.I., et al. (2016) Quercetin Reduces Cyclin D1 Activity and Induces G1 Phase Arrest in HepG2 Cells. Oncology Letters, 12, 516-522. [Google Scholar] [CrossRef] [PubMed]
[29] Zhang, Z., Chen, C., Wang, G., et al. (2011) Aberrant Expression of the p53-Inducible Antiproliferative Gene BTG2 in Hepatocellular Carcinoma Is Associated with Overexpression of the Cell Cycle-Related Proteins. Cell Biochemistry and Biophysics, 61, 83-91. [Google Scholar] [CrossRef] [PubMed]